Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 May 8:5:108.
doi: 10.3389/fphar.2014.00108. eCollection 2014.

Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review

Affiliations
Review

Intraoperative use of remifentanil and opioid induced hyperalgesia/acute opioid tolerance: systematic review

Sang Hun Kim et al. Front Pharmacol. .

Abstract

Introduction: The use of opioids has been increasing in operating room and intensive care unit to provide perioperative analgesia as well as stable hemodynamics. However, many authors have suggested that the use of opioids is associated with the expression of acute opioid tolerance (AOT) and opioid-induced hyperalgesia (OIH) in experimental studies and clinical observations in dose and/or time dependent exposure even when used within the clinically accepted doses. Recently, remifentanil has been used for pain management during anesthesia as well as in the intensive care units because of its rapid onset and offset.

Objectives: Search of the available literature to assess remifentanil AOT and OIH based on available published data.

Methods: We reviewed articles analyzing remifentanil AOT and OIH, and focused our literature search on evidence based information. Experimental and clinical studies were identified using electronic searches of Medline (PubMed, Ovid, Springer, and Elsevier, ClinicalKey).

Results: Our results showed that the development of remifentanil AOT and OIH is a clinically significant phenomenon requiring further research.

Discussions and conclusions: AOT - defined as an increase in the required opioid dose to maintain adequate analgesia, and OIH - defined as decreased pain threshold after chronic opioid treatment, should be suspected with any unexplained pain report unassociated with the disease progression. The clinical significance of these findings was evaluated taking into account multiple methodological issues including the dose and duration of opioids administration, the different infusion mode, the co-administrated anesthetic drug's effect, method assessing pain sensitivity, and the repetitive and potentially tissue damaging nature of the stimuli used to determine the threshold during opioid infusion. Future studies need to investigate the contribution of remifentanil induced hyperalgesia to chronic pain and the role of pharmacological modulation to reverse this process.

Keywords: intraoperative; opioid tolerance; opioid-induced hyperalgesia; postoperative; remifentanil.

PubMed Disclaimer

References

    1. Aguado D., Abreu M., Benito J., Garcia-Fernandez J, Gomez De Segura I. A. (2011). Ketamine and remifentanil interactions on the sevoflurane minimum alveolar concentration and acute opioid tolerance in the rat. Anesth. Analg. 113 505–512 10.1213/ANE.0b013e318227517a - DOI - PubMed
    1. Angst M. S., Chu L. F., Tingle M. S., Shafer S. L., Clark J. D., Drover D. R. (2009). No evidence for the development of acute tolerance to analgesic, respiratory depressant and sedative opioid effects in humans. Pain 142 17–26 10.1016/j.pain.2008.11.001 - DOI - PubMed
    1. Angst M. S., Clark J. D. (2006). Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104 570–587 10.1097/00000542-200603000-00025 - DOI - PubMed
    1. Angst M. S., Koppert W., Pahl I., Clark D. J., Schmelz M. (2003). Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal. Pain 106 49–57 10.1016/S0304-3959(03)00276-8 - DOI - PubMed
    1. Benito J., Aguado D., Abreu M. B., Garcia-Fernandez J, Gomez De Segura I. A. (2010). Remifentanil and cyclooxygenase inhibitors interactions in the minimum alveolar concentration of sevoflurane in the rat. Br. J. Anaesth. 105 810–817 10.1093/bja/aeq241 - DOI - PubMed

LinkOut - more resources